Who Owns ESLA?

Estrella Immunopharma, Inc. — Institutional Ownership & 13F Holdings

$1.03

-0.01 (-0.96%)

Market Cap

$47.1M

Shares Outstanding

Institutional Holders

11

Total Inst. Value

$566K

% of Float Held

QoQ Holder Change

+7

Institutional data as of Q1 2025

New Positions

1

Closed Positions

2

Increased

4

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INC$257K277,578
2GEODE CAPITAL MANAGEMENT, LLC$92K100,173
3CITADEL ADVISORS LLCNew$85K91,599
4UBS Group AG$38K41,034
5ATW SPAC MANAGEMENT LLC$37K40,000
6BlackRock, Inc.$23K24,653
7STATE STREET CORP$20K22,352
8MASO CAPITAL PARTNERS Ltd$9K10,000
9Tower Research Capital LLC (TRC)$5K5,646
10JPMORGAN CHASE & CO$023

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
UBS Group AG-24K$38K
BlackRock, Inc.-465$23K
JPMORGAN CHASE & CO-3$0

Related Stocks

Frequently Asked Questions

How many institutional investors hold ESLA?

As of Q1 2025, 11 institutional investors report holding ESLA (Estrella Immunopharma, Inc.) in their 13F filings.

Which hedge fund owns the most ESLA?

The largest institutional holder of ESLA is VANGUARD GROUP INC with $257K in shares.

Are institutions buying or selling ESLA?

This quarter, 1 institutions opened new positions in ESLA and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.